comparemela.com

Page 5 - ஏரின் ரைட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IDEXX Laboratories Inc (IDXX) Q1 2021 Earnings Call Transcript

IDEXX Laboratories Inc (IDXX) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. IDEXX Laboratories Inc (NASDAQ: IDXX) Popular Searches Operator Good morning, and welcome to the IDEXX Laboratories First Quarter 2021 Earnings Conference Call. As a reminder, today s conference is being recorded. Participating in the call this morning are Jay Mazelsky, President and Chief Executive Officer; Brian McKeon, Chief Financial Officer; and John Ravis, Senior Director, Investor Relations. IDEXX would like to preface the discussion today with a caution regarding forward-looking statements. Listeners are reminded that our discussion during the call will include forward-looking statements that are subject to risk and uncertainties that could cause actual results to differ materially from those discussed today.

PetMed Express Inc (PETS) Q4 2020 Earnings Call Transcript

Operator Welcome to the PetMed Express Incorporated doing business as 1-800-PetMeds Conference Call to Review the Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended on March 31, 2021. At the request of the Company, this conference call is being recorded. Founded in 1996, 1-800-PetMeds is America s most trusted pet pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats and horses, direct to the consumer. 1-800-PetMeds markets its product through national advertising campaign, which direct consumers to order by phone or on the Internet, and aim to increase the recognition of the PetMeds family of brand names. 1-800-PetMeds provides an attractive alternative for obtaining pet medications in terms of convenience, price, ease of ordering and a rapid home delivery.

East Texas homebuilders struggle with rising material prices

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.